ATE101797T1 - Spritzgel-packung, verwendung und darstellung derselben. - Google Patents

Spritzgel-packung, verwendung und darstellung derselben.

Info

Publication number
ATE101797T1
ATE101797T1 AT90106355T AT90106355T ATE101797T1 AT E101797 T1 ATE101797 T1 AT E101797T1 AT 90106355 T AT90106355 T AT 90106355T AT 90106355 T AT90106355 T AT 90106355T AT E101797 T1 ATE101797 T1 AT E101797T1
Authority
AT
Austria
Prior art keywords
spray gel
spray
presentation
same
gel pack
Prior art date
Application number
AT90106355T
Other languages
English (en)
Inventor
Takuzo Kamishita
Takashi Miyazaki
Yoshihide Okuno
Original Assignee
Toko Yakuhin Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1086339A external-priority patent/JPH0623094B2/ja
Priority claimed from JP17258289A external-priority patent/JPH0678245B2/ja
Application filed by Toko Yakuhin Kogyo Kk filed Critical Toko Yakuhin Kogyo Kk
Application granted granted Critical
Publication of ATE101797T1 publication Critical patent/ATE101797T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Otolaryngology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90106355T 1989-04-05 1990-04-03 Spritzgel-packung, verwendung und darstellung derselben. ATE101797T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1086339A JPH0623094B2 (ja) 1989-04-05 1989-04-05 噴霧用ゲル基剤およびそれを用いたゲル剤
JP17258289A JPH0678245B2 (ja) 1989-07-04 1989-07-04 鼻腔内噴霧投与用インフルエンザワクチンゲル製剤

Publications (1)

Publication Number Publication Date
ATE101797T1 true ATE101797T1 (de) 1994-03-15

Family

ID=26427479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90106355T ATE101797T1 (de) 1989-04-05 1990-04-03 Spritzgel-packung, verwendung und darstellung derselben.

Country Status (10)

Country Link
US (1) US5158761A (de)
EP (1) EP0391342B1 (de)
CN (1) CN1046097A (de)
AT (1) ATE101797T1 (de)
AU (1) AU625118B2 (de)
CA (1) CA2012791C (de)
DE (1) DE69006760T2 (de)
DK (1) DK0391342T3 (de)
ES (1) ES2051404T3 (de)
RU (1) RU2028146C1 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776493A (en) * 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
IT1247138B (it) * 1991-03-06 1994-12-12 Dompe Farmaceutici Spa Composizione farmaceutica idrofila contenente ketoprofene sale di lisina per uso topico.
US5248310A (en) * 1992-03-27 1993-09-28 Alza Corporation Oral osmotic device with hydrogel driving member
US5512299A (en) * 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
US5376366A (en) * 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
US5573776A (en) * 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
JP2533723B2 (ja) * 1992-12-28 1996-09-11 東興薬品工業株式会社 速乾性ゲルタイプ手指消毒剤
EP0688205A1 (de) * 1993-03-11 1995-12-27 Secretech, Inc. Mucoadhäsive polymere in der verabreichung von immunogenen an muköse oberflächen
US5500205A (en) * 1994-02-23 1996-03-19 Enviro Pac International, L.I.C. Lachrymator aerosol formulations
GB9408545D0 (en) * 1994-04-29 1994-06-22 Zyma Sa Compositions
ATE223202T1 (de) * 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
DK0885002T3 (da) * 1996-03-04 2011-08-22 Penn State Res Found Materialer og fremgangsmåder til forøgelse af cellulær internalisering
RU2203085C2 (ru) * 1996-07-03 2003-04-27 Элзэ Копэрейшн Стабильный неводный препарат пептидного соединения, способ его получения и способ лечения гормон-зависимого заболевания у субъекта
US5932547A (en) * 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
JP3020141B2 (ja) * 1996-10-07 2000-03-15 株式会社富士薬品 経鼻投与用製剤
US7629384B2 (en) 1997-09-17 2009-12-08 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en) * 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
US6080783A (en) * 1998-09-01 2000-06-27 Gum Tech International, Inc. Method and composition for delivering zinc to the nasal membrane
GB9819366D0 (en) * 1998-09-04 1998-10-28 Unilever Plc Antiperspirant material and compositions containing it
AU759016B2 (en) 1998-10-05 2003-04-03 Penn State Research Foundation, The Compositions and methods for enhancing receptor-mediated cellular internalization
WO2001017556A1 (fr) * 1999-09-07 2001-03-15 Shionogi & Co., Ltd. Préparations vaccinales administrables par les muqueuses
US6398774B1 (en) 1999-09-29 2002-06-04 Heska Corporation Intranasal delivery system
US7678087B2 (en) * 1999-09-29 2010-03-16 Heska Corporation Equine intranasal delivery system
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US20040234457A1 (en) * 1999-10-19 2004-11-25 The Procter & Gamble Company Methods of preventing and treating SARS using low pH respiratory tract compositions
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
US6387858B1 (en) 2000-03-31 2002-05-14 Steris Inc. Safe transport gel for treating medical instruments
WO2003013548A1 (en) * 2001-08-09 2003-02-20 Sekisui Chemical Co., Ltd. Medical composition for external use for dermatosis
WO2004024187A2 (en) * 2002-09-13 2004-03-25 Zicam, Llc. Compositions to reduce congestion and methods for application thereof to the nasal membrane
AU2003268704A1 (en) * 2002-10-01 2004-04-23 Taisho Pharmaceutical Co., Ltd. Nasal drop composition
PL379457A1 (pl) * 2003-01-13 2006-09-18 The Procter & Gamble Company Kompozycje do profilaktyki i leczenia objawów przeziębienia i grypy, zawierające wybrane polimery mukoadhezyjne
EP1454636A1 (de) * 2003-03-04 2004-09-08 Dompé S.P.A. Sterilisierung von Glucocorticoid-Arzneimittelteilchen zur Anwendung in der Lunge
US20050220777A1 (en) * 2003-11-21 2005-10-06 Stefan Roos Selection of lactic acid bacteria enhancing the immune response against Streptococcus pneumoniae
EP1732577B1 (de) * 2004-02-23 2013-04-10 Strategic Science & Technologies, LLC Topische verabreichung von l-arginin zur verbesserung des aussehens von körper und haut
CA2464522C (en) * 2004-04-15 2011-11-15 Eng-Hong Lee Soft gel delivery system for treating poultry
US20110028548A1 (en) * 2004-04-19 2011-02-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
EP2417979A1 (de) * 2004-04-19 2012-02-15 Strategic Science & Technologies, LLC Vorteilhafte Wirkungen der Verstärkung des lokalen Blutflusses
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
WO2005102307A2 (en) * 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
CA2597956C (en) 2005-02-17 2013-07-09 Velcera Pharmaceuticals Transmucosal administration of drug compositions for treating and preventing disorders in animals
US20070059250A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Sprayable personal lubricant
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
BRPI0710654B1 (pt) * 2006-04-21 2021-11-03 Toko Yakuhin Kogyo Kabushiki Kaisha Preparação de adesivo para pele/mucosa do tipo gel, pulverizável, e sistema de administração usando a preparação
ES2775973T3 (es) * 2006-04-21 2020-07-28 Toko Yakuhin Kogyo Kk Recipiente de fluido y sistema de dispensación de fluido sin aire
US20080299182A1 (en) * 2007-03-01 2008-12-04 Shuyuan Zhang Methods and formulations for topical gene therapy
PE20091174A1 (es) * 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
ES2588183T3 (es) 2009-03-31 2016-10-31 Japan As Represented By Director-General Of National Institute Of Infectious Diseases Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal
KR101643797B1 (ko) 2009-06-24 2016-07-28 스트러티직 사이언스 앤드 테크놀로지스, 엘엘씨 이부프로펜을 함유하는 국소 조성물
WO2010151241A1 (en) 2009-06-24 2010-12-29 Strategic Science & Technologies, Llc Topical composition containing naproxen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
WO2011108521A1 (ja) * 2010-03-02 2011-09-09 国立大学法人徳島大学 粘膜ワクチン
US8916171B2 (en) * 2010-04-27 2014-12-23 Topical Sinus Therapeutics, Inc. Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
EP4491225A3 (de) 2010-12-29 2025-03-26 Strategic Science & Technologies, LLC Behandlung von erektiler dysfunktion und anderen indikationen
JP2014501283A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
EP2704687B1 (de) 2011-05-04 2015-07-08 Chiesi Farmaceutici S.p.A. Topische formulierung mit einem corticosteroid als wirkstoff
WO2013031827A1 (ja) 2011-08-29 2013-03-07 国立大学法人徳島大学 Rsv粘膜ワクチン
TR201910293T4 (tr) * 2012-12-28 2019-07-22 Japan As Represented By Director General Of Nat Institute Of Infectious Diseases Nazal influenza aşısı bileşimi.
KR102491446B1 (ko) * 2014-06-25 2023-01-20 도코 야쿠힌 고교 가부시키가이샤 인플루엔자 백신의 경비접종 시스템
US20170035764A1 (en) * 2015-08-03 2017-02-09 Synergistic Therapeutics, Llc Sexual dysfunction therapeutic gel
US10849978B2 (en) * 2015-10-30 2020-12-01 Teijin Pharma Limited Pharmaceutical composition for administration to nasal mucosa
EP3693006A4 (de) * 2017-10-05 2021-07-07 Toko Yakuhin Kogyo Co., Ltd. Nasale hepatitis-b-impfstoffzusammensetzung und verfahren zu ihrer herstellung
CN114585715A (zh) 2019-11-19 2022-06-03 西姆莱斯有限公司 家庭护理产品或制剂
CN114980881A (zh) * 2019-12-06 2022-08-30 东兴药品工业株式会社 包含奥洛他定的鼻用组合物
CN118354795A (zh) * 2021-12-02 2024-07-16 东兴药品工业株式会社 同时靶向鼻粘膜和鼻咽的鼻用疫苗喷雾制剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195076A (en) * 1974-03-05 1980-03-25 Science Union Et Cie, Societe Francaise De Recherche Medicale Process for the preparation of hemagglutinin from viral sources and methods of utilizing same
US3940351A (en) * 1974-07-02 1976-02-24 The B. F. Goodrich Company Polymerization of carboxylic acid monomers and alkyl acrylate esters in chlorofluoroethane
JPS5144618A (en) * 1974-10-07 1976-04-16 Toko Yakuhin Kogyo Kk Kyokushoyozaino seizoho
JPS5467022A (en) * 1977-11-07 1979-05-30 Toko Yakuhin Kogyo Kk Topical agent and production thereof
US4267169A (en) * 1978-07-22 1981-05-12 Toko Yakuhin Kogyo Kabushiki Kaisha Novel preparation of clotrimazole
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4512972A (en) * 1980-06-30 1985-04-23 Kureha Chemical Industry Co., Ltd. Nasal preparation and processes for their production
US4625015A (en) * 1982-08-23 1986-11-25 Scripps Clinic & Research Foundation Broad spectrum influenza antisera
US4495168A (en) * 1983-08-22 1985-01-22 Basf Wyandotte Corporation Aerosol gel
US4717566A (en) * 1984-03-19 1988-01-05 Alza Corporation Dosage system and method of using same
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
DE3586713T2 (de) * 1984-11-15 1993-05-13 Hercon Lab Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
DE3600263A1 (de) * 1986-01-08 1987-07-09 Hoechst Ag Mit fettsaeuren modifizierte polyester, verfahren zu deren herstellung und deren verwendung zur erhoehung der viskositaet in tensidhaltigen praeparaten
JPS63174924A (ja) * 1987-01-14 1988-07-19 Toko Yakuhin Kogyo Kk 軟膏基剤および軟膏剤
US4883660A (en) * 1988-10-17 1989-11-28 Thames Pharmacal Co., Inc. Gel bases for pharmaceutical compositions

Also Published As

Publication number Publication date
RU2028146C1 (ru) 1995-02-09
EP0391342A1 (de) 1990-10-10
DK0391342T3 (da) 1994-03-28
US5158761A (en) 1992-10-27
EP0391342B1 (de) 1994-02-23
ES2051404T3 (es) 1994-06-16
CA2012791A1 (en) 1990-10-05
AU625118B2 (en) 1992-07-02
DE69006760T2 (de) 1994-09-08
DE69006760D1 (de) 1994-03-31
CA2012791C (en) 1997-12-23
CN1046097A (zh) 1990-10-17
AU5290490A (en) 1990-10-11

Similar Documents

Publication Publication Date Title
ATE101797T1 (de) Spritzgel-packung, verwendung und darstellung derselben.
DE69524917D1 (de) Feste pharmazeutische Zusammensetzung mit einem wasserbindenden Hilfsmittel
ATE186638T1 (de) Wirkstoffe und wasserlösliche polymeren enthaltende zubereitungen in form fester teilchen
CA2275587A1 (en) Injectable depot gel composition and method of preparing the composition
ATE192333T1 (de) Partikel mit modifizierten physikalisch- chemischen eigenschaften, ihre herstellung und verwendung
KR930016091A (ko) 거의 수불용성인 약제의 고체 분산액을 제조하는 방법
ES2077023T3 (es) Material de recubrimiento que controla la liberacion de un medicamento para formulaciones de actividad prolongada.
CA2268140A1 (en) Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
ATE197808T1 (de) In wässriger lösung redispergierbare polymerpulver
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
ES543595A0 (es) Procedimiento para preparar composiciones biologicamente activas a base de biocidas en otros ingredientes activos polimeros hidrofilos y sales inorganicas.
RU95103923A (ru) Производные бензимидазола, смесь их изомеров или отдельные изомеры и их соли и фармацевтическая композиция с антагонистической в отношении ангиотензина активностью на их основе
PT615754E (pt) Formas solidas de administracao oral de libertacao controlada flupertina
BR9206109A (pt) Agentes modeladores para os cabelos e composições contendo polímeros hidrofóbicos modeladores dos cabelos.
GB1465665A (en) Topical composition
ES8103999A1 (es) Procedimiento de preparar agentes pulverulentos y pastosos.
ATE47313T1 (de) Arzneimittelumhuellung.
ATE258446T1 (de) Benzophenanthridinalkaloid-enthaltende pestizide
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
DE59107240D1 (de) Emulgatorfreie Emulsionspolymere in pharmazeutischen Zubereitungen mit verzögerter Wirkstofffreigabe und ihre Herstellung
IL93721A0 (en) Mixed micelles compositions and their use as carriers for the parenteral application of the drugs
DE69724328D1 (de) Konjugate von einem Interleukin-2 Rezeptor spezifisch erkennenden Faktor mit Ribonuklease
KR900004251A (ko) 수중-부유성 및 응집성의 고형 농업용 제제
IT8723007A0 (it) Composizioni farmaceutiche per uso orale ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo, e procedimento per prepararle
CA2244679A1 (en) Tranilast-containing preparation for external application and method of producing the same

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time